Skip to main content
. 2015 Jan 5;10(1):e0116274. doi: 10.1371/journal.pone.0116274

Figure 5. Effects of SB216763, LY-294002, and rosiglitazone treatment on LDH release.

Figure 5

Each bar represents LDH release (unit/ml). Hearts were treated with (A) p-AKT inhibitor (10μM LY-294002, p-AKTi), (B) GSK3β inhibitor (3µM SB216763, GSK3βi), and (C) Rosiglitazone, each of them administrated individual or in association with n-3 TG. n = 3–4 mice hearts/group Data represent means ± SD, determined by ANOVA analysis.